Molucular analysis of tissue distribution and structure-function relationship of transporters responsible for the regulation of drug transport

负责药物转运调节的转运蛋白的组织分布和结构功能关系的分子分析

基本信息

  • 批准号:
    08457620
  • 负责人:
  • 金额:
    $ 5.57万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

Tissue distribution and structure-function relationship of membrane transporters responsible for absorption and excretion of drugs have been studied, and then following results were obtained.1.Structure-function relationship of H^+-coupled peptide transportersWhen stable transfectans expressing rat peptide transporters PEPT1 and PEPT2 were treated with DEPC, a histidine-modifying agent, glycylsarcosine uptake by both transfectants were decreased. Interactions of dipeptides and beta-lactam antibiotics were analyzed, and then it became clear that alpha-amino moiety of beta-lactam antibiotics should interact with histidine residues, and may participate in substrate recognition.2.Tissue distribution and functional characteristics of renal organic ion transporters.(1)Organic anion transporter, OAT-K1 : Expression of mRNA along nephron segments was analyzed by RT-PCR.OAT-K1 mRNAs were mainly expressed in proximal straight tubules of superficial and juxtamedullary nephrons. Western blot analysis revealed that OAT-K1 is expressed only in brush-border membranes of renal tubules. Methotrexate transport by the transfectants stably expressing OAT-K1 was significantly inhibited in the presence of nonsteroidal anti-inflammatory drugs (NSAID).(2)Organic cation transporter, OCT2 : Because tetraethylammonium transport by OCT2 was H^+-gradient independent and was affected by membrane potential, OCT2 is deduced to be basolateral-type organic cation transporter. By constructing stable transfectants expressing OCT1 or OCT2, transport characteristics were further analyzed, and then it became clear that both OCT1 and OCT2 are basolateral-type organic cation transporters with broad substrate specificity and have similar substate recognition in each other.
对负责药物吸收和排泄的膜转运蛋白的组织分布和结构-功能关系进行了研究,得到了以下结果:1.H^+偶联肽转运蛋白的结构-功能关系稳定转染子表达大鼠肽转运蛋白PEPT1和PEPT2 用组氨酸修饰剂 DEPC 处理,两种转染子对甘氨酰肌氨酸的摄取均减少。通过分析二肽与β-内酰胺类抗生素的相互作用,明确β-内酰胺类抗生素的α-氨基部分应与组氨酸残基相互作用,并可能参与底物识别。2.肾脏有机离子的组织分布和功能特征(1)有机阴离子转运蛋白OAT-K1:通过RT-PCR分析沿肾单位节段mRNA的表达。OAT-K1 mRNA主要在近端直链表达浅肾小管和近髓肾单位。 Western blot 分析显示,OAT-K1 仅在肾小管刷状缘膜中表达。在非甾体抗炎药 (NSAID) 存在下,稳定表达 OAT-K1 的转染子的甲氨蝶呤转运受到显着抑制。 (2)有机阳离子转运蛋白 OCT2 :因为 OCT2 的四乙铵转运不依赖于 H^+ 梯度,因此受到影响通过膜电位推测OCT2是基底外侧型有机阳离子转运蛋白。通过构建表达OCT1或OCT2的稳定转染子,进一步分析转运特性,发现OCT1和OCT2都是基底外侧型有机阳离子转运蛋白,具有广泛的底物特异性,并且彼此具有相似的底物识别能力。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Terada: "Characterization of stably transfected kideny epithelial cell line expressing rat H^+/peptide cotransporter PEPT1 : localization of PEPT1 and transport of β-lactam antibiotics." J.Pharmacol.Exp.Ther.281(3). 1415-1421 (1997)
T.Terada:“表达大鼠 H^+/肽协同转运蛋白 PEPT1 的稳定转染肾上皮细胞系的表征:PEPT1 的定位和 β-内酰胺抗生素的转运。”J.Pharmacol.Exp.Ther.281(3)。 1421 (1997)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Masuda et al.: "Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1" J.Pharmacol.Exp.Ther.283(3). 1039-1042 (1997)
S.Masuda 等人:“非甾体抗炎药与大鼠肾有机阴离子转运蛋白 OAT-K1 的相互作用”J.Pharmacol.Exp.Ther.283(3)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Okuda et al.: "Characterization of organic ion transporters involved in renal excretion of xenobiotics." Jpn.J.Physiol.47(S1). S58-S59 (1997)
M.Okuda 等人:“参与异生物质肾脏排泄的有机离子转运蛋白的表征。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Terada: "Identification of the histidine residuesninvolved in substrate recognitopn by a rat H^+/peptide cotransporter,PEPT1" FEBS Lett.394・2. 196-200 (1996)
T.Terada:“大鼠 H^+/肽协同转运蛋白,PEPT1 参与底物识别的组氨酸残基的鉴定”FEBS Lett.394·2 (1996)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Saito: "Cloning and functional characterization of a novel rat organic anion transporter medeating basolateral uptake of methotrexate in the kidney" J.Biol.Chem.271・34. 20719-20725 (1996)
H.Saito:“介导肾脏基底外侧摄取甲氨蝶呤的新型大鼠有机阴离子转运蛋白的克隆和功能表征”J.Biol.Chem.271·34(1996)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INUI Ken-ichi其他文献

INUI Ken-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INUI Ken-ichi', 18)}}的其他基金

PHARMACOKINETICS IN THE PATIENTS WITH METABOLIC SYNDROME AND APPLICATION FOR PHARMACOTHERAPY
代谢综合征患者的药代动力学及其在药物治疗中的应用
  • 批准号:
    20249036
  • 财政年份:
    2008
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Establishment of personalized immunosuppressive therapy based on molecular mechanisms of transplant immunological network
基于移植免疫网络分子机制建立个体化免疫抑制治疗
  • 批准号:
    16209005
  • 财政年份:
    2004
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Evaluation of drug interaction and interindividual differences of renal drug excretion based on the genetic polymorphism analysis
基于遗传多态性分析评价药物相互作用及肾脏药物排泄个体差异
  • 批准号:
    13307068
  • 财政年份:
    2001
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular diversity of organic ion transporters and their roles in the renal drug excretion
有机离子转运蛋白的分子多样性及其在肾脏药物排泄中的作用
  • 批准号:
    11470495
  • 财政年份:
    1999
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of novel systems for evaluation and prediction of drug inteactions based on the reconstruction of drug excretion systems in vitro.
基于体外药物排泄系统重建的药物相互作用评估和预测的新系统的开发。
  • 批准号:
    09557211
  • 财政年份:
    1997
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Kietic analysis and evaluation of drug absorption and excretion using cultured cells.
使用培养细胞进行药物吸收和排泄的动力学分析和评估。
  • 批准号:
    07557145
  • 财政年份:
    1995
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular and Cell Biological Analyzes of Structure and Function of Drug Transporters in the Intestine and Kidney Proximal Tubule
肠和肾近端小管药物转运蛋白结构和功能的分子和细胞生物学分析
  • 批准号:
    06454596
  • 财政年份:
    1994
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Structure and Function of Drug Transporters in the Intestinal and Renal Epithelial Cells
肠和肾上皮细胞中药物转运蛋白的结构和功能
  • 批准号:
    02807200
  • 财政年份:
    1990
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Regulation Mechanisms of Drug Disposition via H^+-Coupled Active Transport Systems in the Intestinal and Renal Tubular Epithelial Cells
肠和肾小管上皮细胞中H^耦合主动转运系统的药物处置调节机制
  • 批准号:
    63571092
  • 财政年份:
    1988
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Studies on inhibitory activity of thrombospondin in biomineralization.
血小板反应蛋白生物矿化抑制活性的研究。
  • 批准号:
    09671896
  • 财政年份:
    1997
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of procedures to enhance the expression of introduced genes in mammalian cells.
建立增强哺乳动物细胞中导入基因表达的程序。
  • 批准号:
    04650877
  • 财政年份:
    1992
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了